Josamycin
![]() | |
![]() | |
Clinical data | |
---|---|
AHFS/Drugs.com | International Drug Names |
ATC code | J01FA07 (WHO) |
Identifiers | |
| |
CAS Number |
16846-24-5 ![]() |
PubChem (CID) | 5284579 |
DrugBank |
DB01321 ![]() |
ChemSpider |
4447629 ![]() |
UNII |
HV13HFS217 ![]() |
KEGG |
D01235 ![]() |
ChEBI |
CHEBI:31739 ![]() |
ChEMBL |
CHEMBL224436 ![]() |
PDB ligand ID | JOS (PDBe, RCSB PDB) |
ECHA InfoCard | 100.037.140 |
Chemical and physical data | |
Formula | C42H69NO15 |
Molar mass | 827.995 g/mol |
3D model (Jmol) | Interactive image |
| |
| |
![]() ![]() |
Josamycin is a macrolide antibiotic. It is synthesized from strains of Streptomyces narbonensis var. josamyceticus var. nova
Currently sold in various countries.
Brand examples are:
Europe: Josalid, Josacine, Iosalide, Josamina. Russia: Wilprafen (Вильпрафен). Japan: Josamy.
Adverse effects
There has been a case report of oedema of the feet.[1]
References
- ↑ Bosch, X.; Pedrol, E.; Casado, X.; Urbano-Marquez, A. (1993). "Josamycin-induced pedal oedema" (pdf). British Medical Journal (Clinical research ed.). 307 (6895): 26. doi:10.1136/bmj.307.6895.26-a. PMC 1678472
. PMID 8343666.
This article is issued from Wikipedia - version of the 7/10/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.